Cargando…
Therapeutic effects of pentoxifylline on invasive pulmonary aspergillosis in immunosuppressed mice
BACKGROUND: The most common and severe infection of Aspergillus fumigatus is invasive pulmonary aspergillosis (IPA), which is usually seen in immunocompromised patients. Neutropenia is the primary risk factor implicated in IPA; however, IPA also occurs in patients without neutropenia, namely, those...
Autores principales: | Feng, Chunlai, Zhang, Ming, Zhang, Sujuan, Zhang, Jun, Li, Chong, Zhou, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814429/ https://www.ncbi.nlm.nih.gov/pubmed/33468116 http://dx.doi.org/10.1186/s12890-021-01396-8 |
Ejemplares similares
-
The role of pentraxin3 in plasma and bronchoalveolar lavage fluid in COPD patients with invasive pulmonary aspergillosis
por: He, Qian, et al.
Publicado: (2021) -
Diagnosis values of Dectin-1 and IL-17 levels in plasma for invasive pulmonary aspergillosis in bronchiectasis
por: He, Qian, et al.
Publicado: (2022) -
Semi-invasive pulmonary aspergillosis in an immunosuppressed patient: a case report
por: Cabral, Fernanda C, et al.
Publicado: (2009) -
Invasive Pulmonary Aspergillosis: Not Only a Disease Affecting Immunosuppressed Patients
por: Zaragoza, Rafael, et al.
Publicado: (2023) -
Pentoxifylline Inhibits Pulmonary Fibrosis by Regulating Cellular Senescence in Mice
por: Lin, Yifan, et al.
Publicado: (2022)